|
1
|
Semenza GL: Hypoxia and human disease -
and the Journal of Molecular Medicine. J Mol Med Berl.
85:1293–1294. 2007. View Article : Google Scholar
|
|
2
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Semenza GL: Hypoxia-inducible factor 1
(HIF-1) pathway. Sci STKE. 2007:cm82007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mirzoeva S, Kim ND, Chiu K, Franzen CA,
Bergan RC and Pelling JC: Inhibition of HIF-1 alpha and VEGF
expression by the chemopreventive bioflavonoid apigenin is
accompanied by Akt inhibition in human prostate carcinoma PC3-M
cells. Mol Carcinog. 47:686–700. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim DH, Hossain MA, Kim MY, Kim JA, Yoon
JH, Suh HS, Kim GY, Choi YH, Chung HY and Kim ND: A novel
resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and
VEGF expression, and migration in human prostate cancer cells. Int
J Oncol. 43:1915–1924. 2013.PubMed/NCBI
|
|
6
|
Chen MC, Lee CF, Huang WH and Chou TC:
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of
HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Biochem Pharmacol. 85:1278–1287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao H, Wang H, Zhang Z, Jiang BH, Luo J
and Shi X: Sulforaphane inhibited expression of hypoxia-inducible
factor-1alpha in human tongue squamous cancer cells and prostate
cancer cells. Int J Cancer. 123:1255–1261. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jo GH, Kim GY, Kim WJ, Park KY and Choi
YH: Sulforaphane induces apoptosis in T24 human urinary bladder
cancer cells through a reactive oxygen species-mediated
mitochondrial pathway: The involvement of endoplasmic reticulum
stress and the Nrf2 signaling pathway. Int J Oncol. 45:1497–1506.
2014.PubMed/NCBI
|
|
9
|
Wang M, Zhu JY, Chen S, Qing Y, Wu D, Lin
YM, Luo JZ, Han W and Li YQ: Effects of co-treatment with
sulforaphane and autophagy modulators on uridine
5′-diphospho-glucuronosyltransferase 1A isoforms and cytochrome
P450 3A4 expression in Caco-2 human colon cancer cells. Oncol Lett.
8:2407–2416. 2014.PubMed/NCBI
|
|
10
|
Juge N, Mithen RF and Traka M: Molecular
basis for chemoprevention by sulforaphane: A comprehensive review.
Cell Mol Life Sci. 64:1105–1127. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fahey JW and Talalay P: Antioxidant
functions of sulforaphane: A potent inducer of Phase II
detoxication enzymes. Food Chem Toxicol. 37:973–979. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kraft AD, Johnson DA and Johnson JA:
Nuclear factor E2-related factor 2-dependent antioxidant response
element activation by tert-butylhydroquinone and sulforaphane
occurring preferentially in astrocytes conditions neurons against
oxidative insult. J Neurosci. 24:1101–1112. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boddupalli S, Mein JR, Lakkanna S and
James DR: Induction of phase 2 antioxidant enzymes by broccoli
sulforaphane: Perspectives in maintaining the antioxidant activity
of vitamins A, C, and E. Front Genet. 3:72012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Liu J and Chen SY: Sulforaphane
protects against ethanol-induced oxidative stress and apoptosis in
neural crest cells by the induction of Nrf2-mediated antioxidant
response. Br J Pharmacol. 169:437–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gamet-Payrastre L, Li P, Lumeau S, Cassar
G, Dupont MA, Chevolleau S, Gasc N, Tulliez J and Tercé F:
Sulforaphane, a naturally occurring isothiocyanate, induces cell
cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer
Res. 60:1426–1433. 2000.PubMed/NCBI
|
|
16
|
Pledgie-Tracy A, Sobolewski MD and
Davidson NE: Sulforaphane induces cell type-specific apoptosis in
human breast cancer cell lines. Mol Cancer Ther. 6:1013–1021. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeon YK, Yoo DR, Jang YH, Jang SY and Nam
MJ: Sulforaphane induces apoptosis in human hepatic cancer cells
through inhibition of
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase4, mediated by
hypoxia inducible factor-1-dependent pathway. Biochim Biophys Acta.
1814:1340–1348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Parnaud G, Li P, Cassar G, Rouimi P,
Tulliez J, Combaret L and Gamet-Payrastre L: Mechanism of
sulforaphane-induced cell cycle arrest and apoptosis in human colon
cancer cells. Nutr Cancer. 48:198–206. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang M, Chen S, Wang S, Sun D, Chen J, Li
Y, Han W, Yang X and Gao HQ: Effects of phytochemicals sulforaphane
on uridine diphosphate-glucuronosyltransferase expression as well
as cell-cycle arrest and apoptosis in human colon cancer Caco-2
cells. Chin J Physiol. 55:134–144. 2012.PubMed/NCBI
|
|
20
|
Chung FL, Conaway CC, Rao CV and Reddy BS:
Chemo-prevention of colonic aberrant crypt foci in Fischer rats by
sulforaphane and phenethyl isothiocyanate. Carcinogenesis.
21:2287–2291. 2000. View Article : Google Scholar
|
|
21
|
Hu R, Khor TO, Shen G, Jeong WS, Hebbar V,
Chen C, Xu C, Reddy B, Chada K and Kong AN: Cancer chemoprevention
of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural
product derived from cruciferous vegetable. Carcinogenesis.
27:2038–2046. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Semenza GL: Regulation of hypoxia-induced
angiogenesis: A chaperone escorts VEGF to the dance. J Clin Invest.
108:39–40. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Semenza GL: Involvement of
hypoxia-inducible factor 1 in human cancer. Intern Med. 41:79–83.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Denes V, Lakk M, Makarovskiy A, Jakso P,
Szappanos S, Graf L, Mandel L, Karadi I and Geck P: Metastasis
blood test by flow cytometry: In vivo cancer spheroids and the role
of hypoxia. Int J Cancer. 136:1528–1536. 2015. View Article : Google Scholar
|
|
25
|
Liu ZJ, Semenza GL and Zhang HF:
Hypoxia-inducible factor 1 and breast cancer metastasis. J Zhejiang
Univ Sci B. 16:32–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pugh CW and Ratcliffe PJ: The von
Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1)
degradation, and cancer pathogenesis. Semin Cancer Biol. 13:83–89.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rudolf E and Cervinka M: Sulforaphane
induces cytotoxicity and lysosome- and mitochondria-dependent cell
death in colon cancer cells with deleted p53. Toxicol In Vitro.
25:1302–1309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hubbi ME, Hu H, Kshitiz, Ahmed I,
Levchenko A and Semenza GL: Chaperone-mediated autophagy targets
hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation. J
Biol Chem. 288:10703–10714. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kwak MK, Cho JM, Huang B, Shin S and
Kensler TW: Role of increased expression of the proteasome in the
protective effects of sulforaphane against hydrogen
peroxide-mediated cytotoxicity in murine neuroblastoma cells. Free
Radic Biol Med. 43:809–817. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gan N, Wu YC, Brunet M, Garrido C, Chung
FL, Dai C and Mi L: Sulforaphane activates heat shock response and
enhances proteasome activity through up-regulation of Hsp27. J Biol
Chem. 285:35528–35536. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Balasubramanian S, Chew YC and Eckert RL:
Sulforaphane suppresses polycomb group protein level via a
proteasome-dependent mechanism in skin cancer cells. Mol Pharmacol.
80:870–878. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jung DB, Lee HJ, Jeong SJ, Lee HJ, Lee EO,
Kim YC, Ahn KS, Chen CY and Kim SH: Rhapontigenin inhibited hypoxia
inducible factor 1 alpha accumulation and angiogenesis in hypoxic
PC-3 prostate cancer cells. Biol Pharm Bull. 34:850–855. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kensler TW, Egner PA, Agyeman AS,
Visvanathan K, Groopman JD, Chen JG, Chen TY, Fahey JW and Talalay
P: Keap1-nrf2 signaling: A target for cancer prevention by
sulforaphane. Top Curr Chem. 329:163–177. 2013. View Article : Google Scholar :
|
|
34
|
Zhang C, Su ZY, Khor TO, Shu L and Kong
AN: Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP
C1 cells through epigenetic regulation. Biochem Pharmacol.
85:1398–1404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Herman-Antosiewicz A, Johnson DE and Singh
SV: Sulforaphane causes autophagy to inhibit release of cytochrome
c and apoptosis in human prostate cancer cells. Cancer Res.
66:5828–5835. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Naumann P, Fortunato F, Zentgraf H,
Büchler MW, Herr I and Werner J: Autophagy and cell death signaling
following dietary sulforaphane act independently of each other and
require oxidative stress in pancreatic cancer. Int J Oncol.
39:101–109. 2011.PubMed/NCBI
|
|
37
|
Zhang J, Cao J, Ma S, Dong R, Meng W, Ying
M, Weng Q, Chen Z, Ma J, Fang Q, et al: Tumor hypoxia enhances
non-small cell lung cancer metastasis by selectively promoting
macrophage M2 polarization through the activation of ERK signaling.
Oncotarget. 5:9664–9677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsuo Y, Ding Q, Desaki R, Maemura K,
Mataki Y, Shinchi H, Natsugoe S and Takao S: Hypoxia inducible
factor-1 alpha plays a pivotal role in hepatic metastasis of
pancreatic cancer: An immunohistochemical study. J Hepatobiliary
Pancreat Sci. 21:105–112. 2014. View
Article : Google Scholar
|
